Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome

Author： Yasuda H.   Niki H.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.2, 2002-01, pp. : 67-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab shows potential in patients with primary Sjögren's syndrome

By  

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Xerostomia Secondary to Sjögren’s Syndrome in the Elderly: Recognition and Management

By Al-Hashimi Ibtisam  

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 887-899

Adis International

Access to resources Recommend Favorite

CNS Involvement in Primary Sjögren's Syndrome: Prevalence, Clinical Aspects, Diagnostic Assessment and Therapeutic Approach

By Govoni M.   Padovan M.   Rizzo N.   Trotta F.  

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 597-607

Adis International

Access to resources Recommend Favorite

Paclitaxel: Cutaneous lupus erythematosus in patients with Sjögren's syndrome: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1172, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Rational Drug Therapy Recommendations for the Treatment of Patients with Sjögren's Syndrome

By Oxholm P.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite